Associations of tissue tumor mutational burden and mutational status with clinical outcomes in KEYNOTE-042: pembrolizumab versus chemotherapy for advanced PD-L1-positive NSCLC

Autor:	T.S.K. Mok, G. Lopes, B.C. Cho, D.M. Kowalski, K. Kasahara, Y.-L. Wu, G. de Castro, H.Z. Turna, R. Cristescu, D. Aurora-Garg, A. Loboda, J. Lunceford, J. Kobie, M. Ayers, M.C. Pietanza, B. Piperdi, R.S. Herbst
Rok vydání:	2023
Předmět:	Oncology Hematology
Zdroj:	Annals of Oncology. 34:377-388
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2023.01.011
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::1eb4b3d4ad325b17ae200d52d533a11f https://doi.org/10.1016/j.annonc.2023.01.011 Zobrazit plný text záznamu